Effect of omalizumab treatment in a baker with occupational asthma.
Pérez Pimiento
A
A
Department of Allergy, Hospital Universitario Puerta de Hierro, Madrid, Spain. aperezpimiento@yahoo.es
Bueso Fernández
A
A
García Loria
J
J
Rodríguez Cabreros
M I
MI
Mosquera
M R
MR
García Cubero
A
A
D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D005500:Follow-Up Studies; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007167:Immunotherapy; D008297:Male; D009784:Occupational Diseases / Q000188:drug therapy* / Q000276:immunology; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E